April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
Mortality and Ocular Diseases. The Beijing Eye Study
L. Xu; Y. Wang; J. Wang; J. Jonas
Author Affiliations & Notes
  • L. Xu
    Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Capital University of Medical Science, Beijing, China
  • Y. Wang
    Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Capital University of Medical Science, Beijing, China
  • J. Wang
    Beijing Inst Ophthal/Chongwen Dist, Beijing Tongren Hospital, Beijing, China
  • J. Jonas
    Beijing Inst Ophthal/Chongwen Dist, Beijing Tongren Hospital, Beijing, China
    ) Department of Ophthalmology, Faculty of Clinical Medicine Mannheim, University of Heidelberg,Mannheim, Germany
  • Footnotes
    Commercial Relationships  L. Xu, None; Y. Wang, None; J. Wang, None; J. Jonas, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 436. doi:
  • Views
  • Share
  • Tools
    • Alerts
      User Alerts
      You are adding an alert for:
      Mortality and Ocular Diseases. The Beijing Eye Study
      You will receive an email whenever this article is corrected, updated, or cited in the literature. You can manage this and all other alerts in My Account
      The alert will be sent to:
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation
      Citation

      L. Xu, Y. Wang, J. Wang, J. Jonas; Mortality and Ocular Diseases. The Beijing Eye Study. Invest. Ophthalmol. Vis. Sci. 2009;50(13):436.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

      ×
    • Get Permissions
  • Supplements
Abstract

Purpose: : To examine the relationship between mortality and major ocular diseases in a Population-based study

Methods: : At baseline in 2001, the Beijing Eye Study examined 4439 subjects with an age of 40+ years. The mean age was 56.2±10.6 years (40-101 years). The participants underwent a detailed ophthalmic examination and answered questions on the socioeconomic background. In 2006, all study participants were re-invited for a follow-up examination. Rate of mortality was determined in the follow-up survey of 2006.

Results: : Out of the 4439 subjects examined in the 2001, 3251 (73.2%) subjects returned for the follow-up examination, while 143 (3.2%) subjects were dead and 1045 (23.5%) subjects were alive however did not agree to be re-examined. In binary logistic regression analysis, mortality was significantly associated with the systemic parameters of higher age (P<0.001; Odds ratio (OR):1.07), male gender (P=0.01;OR:0.55), lower level of education (P<0.001;OR:0.65), and smoking (P=0.023;OR:1.25), and with the ocular parameters of level of diabetic-like retinopathy (P=0.036;OR:1.02), presence of angle-closure glaucoma (P=0.013;OR:3.74), and presence of non-glaucomatous optic nerve damage (P=0.027;OR:3.41). Presence of retinal vein occlusions was marginally associated with mortality (P=0.059;OR=2.59). Mortality was not significantly associated with best corrected visual acuity (P=0.14) in multivariate analysis, nor with age-related macular degeneration, open-angle glaucoma, trachoma, any type of cataract, visual field defects, intraocular pressure and refractive error.

Conclusions: : If socioeconomic parameters, age, gender and smoking were taken into account, ocular parameters associated with an increased mortality were diabetic-like retinopathy, angle-closure glaucoma, and non-glaucomatous optic nerve damage. Retinal vein occlusions were marginally associated. Other major ocular disorders such as any form of cataract, open-angle glaucoma, age-related macular degeneration, trachoma, pterygia, and high myopia or high hyperopia were not significantly related with mortality.

Keywords: clinical (human) or epidemiologic studies: health care delivery/economics/manpower • aging • proliferative vitreoretinopathy 
© 2009, The Association for Research in Vision and Ophthalmology, Inc., all rights reserved. Permission to republish any abstract or part of an abstract in any form must be obtained in writing from the ARVO Office prior to publication.
Copyright © 2025 Association for Research in Vision and Ophthalmology.
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept